Novo Nordisk A/S (NVO)

NVO on New York Consolidated

69.52USD
9 Feb 2010
Price Change (% chg)

$0.38 (+0.55%)
Prev Close
$69.52
Open
--
Day's High
$70.36
Day's Low
$68.84
Volume
1,013,299
Avg. Vol
425,272
52-wk High
$71.45
52-wk Low
$41.35

NVO

Chart for NVO

About

Novo Nordisk A/S is a Denmark-based health care company. It also focuses within areas, such as haemostasis management, growth hormone therapy and hormone replacement therapy. The Company operates in two business segments: diabetes care and biopharmaceuticals. The Company’s products include Victoza, NovoRapid, NovoSeven, Levemir,... (more)

Overall

Beta: 0.32
Market Cap (Mil.): $43,101.98
Shares Outstanding (Mil.): 620.00
Annual Dividend: 1.41
Yield (%): 2.02

Financials

  NVO Industry Sector
P/E (TTM): 21.16 1.96 3.76
EPS (TTM): 14.59 -- --
ROI: 27.27 0.92 2.30
ROE: 31.34 1.27 2.82
view overview for:

Competitors

  Price Change
Eli Lilly & Co. (LLY.N) $35.20 +0.42
Sanofi-Aventis SA (SASY.PA) €52.49 -0.17
Pfizer Inc. (PFE.N) $17.88 +0.04
GlaxoSmithKline plc (GSK.L) £1,201.50 -17.00
Merck & Co., Inc. (MRK.N) $36.47 -0.12
Abbott Laboratories (ABT.N) $53.35 0.00
Wyeth (WYE.N) -- --
Wyeth (WYE_p.N) -- --
Bristol Myers Squibb Co. (BMY.N) $24.25 +0.29
Bristol Myers Squibb Co. (BMY_p.N) $439.50 0.00

  Earnings  vs    Estimates

view overview for: